Sacubitril/valsartan initiation among renin-angiotensin aldosterone system inhibitor-naive heart failure patients with reduced ejection fraction

Back

HFA Premium Access

Sacubitril/valsartan initiation among renin-angiotensin aldosterone system inhibitor-naive heart failure patients with reduced ejection fraction

Session: Heart failure prognosis and the options to improve

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor A. Mohanty (Salt Lake City, US)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Doctor April Mohanty

University of Utah, Salt Lake City (United States of America)

0 follower

14 more presentations in this session

The impact of anthropometric measures of obesity on heart failure outcomes in Asia

Speaker: Doctor C. Chandramouli (Singapore, SG)

S2PLIT Score: a simple risk score predicting post-discharge 1-year mortality in patients with acutely decompensated heart failure

Speaker: Mr J. Borovac (Split, HR)

Increased all-cause mortality in newly diagnosed patients with heart failure between 2006 and 2012: a retrospective, population-based study in Sweden

Speaker: Professor K. Lindmark (Umea, SE)

Access

Slides

Video

One year follow-up of heart failure patients: role of the new tnm-like classification

Speaker: Doctor M. Pucci (Rome, IT)

High-dose loop diuretics are associated with adverse clinical outcomes in outpatients with chronic heart failure and mid-range and preserved ejection fraction: observations from the ESC Heart Failure

Speaker: Doctor C. Kapelios (Athens, GR)

Access the full session

Heart failure prognosis and the options to improve

Speakers: Doctor A. Mohanty, Doctor C. Chandramouli, Mr J. Borovac, Professor K. Lindmark, Doctor M. Pucci...

Access

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources